Related Experiment Videos
Regulation of the immune response by prostaglandins
Clinical Immunology and Immunopathology
|January 1, 1980
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Patient-reported outcomes after 10-year follow-up of intensive, multifactorial treatment in individuals with screen-detected type 2 diabetes: the ADDITION-Europe trial.
Diabetic medicine : a journal of the British Diabetic Association·2020
Selectivity of beta-blockers, cardiovascular and all-cause mortality in people with hypoglycaemia: An observational study.
Nutrition, metabolism, and cardiovascular diseases : NMCD·2019
Moderate increases in daily step count are associated with reduced IL6 and CRP in women with PCOS.
Endocrine connections·2018
Cardiovascular risk factors and incident albuminuria in screen-detected type 2 diabetes.
Diabetes/metabolism research and reviews·2016
D-penicillamine-induced pancreatic islet autoantibody production is independent of the immunogenetic background: a lesson from patients with Wilson's disease.
Clinical immunology and immunopathology·1998
Characterization of gastric Na+/I- symporter of the rat.
Clinical immunology and immunopathology·1998
CD8(+), radiosensitive T cells of parental origin, oppose cells capable of down-regulating cytotoxicity in murine acute lethal graft-versus-host disease.
Clinical immunology and immunopathology·1998
Specific activity of alpha1proteinase inhibitor and alpha2macroglobulin in human serum: application to insulin-dependent diabetes mellitus.
Clinical immunology and immunopathology·1998
Somatic hypermutation in T-independent and T-dependent immune responses to Haemophilus influenzae type b polysaccharide.
Clinical immunology and immunopathology·1998
Treatment with progesterone analogues decreases macrophage Fcgamma receptors expression.
Clinical immunology and immunopathology·1998
Epigenetic Regulation of Host Immunity During Parasitic Infections: Mechanisms, Immune Evasion, and Therapeutic Opportunities.
Immunological investigations·2026
Elevated Markers of Intestinal Barrier Dysfunction and TLR2 Ligands in Individuals with Type 1 Diabetes.
Diabetes, metabolic syndrome and obesity : targets and therapy·2026